003000 — Bukwang Pharm Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩405bn
- KR₩341bn
- KR₩126bn
- 27
- 16
- 33
- 10
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1,362 | -8,300 | 3,787 | -1,033 | -39,569 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 12,113 | 20,755 | 7,676 | 8,159 | 490 |
Unusual Items | |||||
Purchased R&D | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -39,998 | -17,890 | 10,219 | 4,219 | 25,425 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -23,408 | 723 | 26,525 | 16,461 | -9,362 |
Capital Expenditures | -4,906 | -1,954 | -790 | -4,990 | -2,835 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 22,991 | 15,002 | 5,539 | 1,839 | 516 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 18,085 | 13,048 | 4,749 | -3,151 | -2,319 |
Financing Cash Flow Items | -21.1 | -947 | -291 | -3,218 | -1,139 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -57,481 | 28,232 | -27,485 | -10,398 | 76,839 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -62,815 | 41,706 | 3,486 | 2,740 | 65,710 |